A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

Completed · Phase 2

Conditions studied: Urinary Incontinence, Urge

In brief

The purpose of this study is to determine the safety of three doses of oxybutynin for the treatment of urge urinary incontinence.

Key facts

Study ID

NCT00749632

Run by

FemmePharma Global Healthcare, Inc.

People needed

45

Starts

2007-07-01

Expected to finish

2008-10-01

Last updated by the study team

2009-10-15

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females 18 to 75 years of age
• Has reported symptoms of urge urinary incontinence/overactive bladder

You may not qualify if…

• Is pregnant or lactating
• Has had lower urinary tract surgery within 6 months prior to Screening
• Has a history of urinary retention

Where it is running

• SNBL Clinical Pharmacology Center — Baltimore, Maryland, United States
• Advanced Biomedical Research — Hackensack, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.